Arrow Translation Partners with Novo Nordisk to Provide Expert Pharmaceutical Translation Services

Arrow Translation is pleased to announce a strategic collaboration with Novo Nordisk, a global leader in the diabetes field, to provide high-quality pharmaceutical translation services. This partnership will offer Novo Nordisk precise language support for its global operations and research in diabetes treatment.

Novo Nordisk is renowned for its commitment to developing innovative diabetes treatments and improving patients' quality of life. To effectively communicate and collaborate across borders, Novo Nordisk requires high-quality translation services, particularly in clinical trials, drug registration, and academic research.

Arrow Translation, with its expertise in the pharmaceutical industry, will provide accurate translations of product labels, clinical research reports, scientific papers, and marketing materials. The services will ensure seamless communication across global markets, helping Novo Nordisk advance its mission in the diabetes treatment field.

◀️：Arrow Translation Provides Legal Interpretation Services for Xiaomi Corporation

▶️：Arrow Translation Partners with Sanofi to Offer Precision Pharmaceutical Translation Services